Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G. Johns, Harold B. Wood, Erik D. Guetschow et al.|Circulation|2023Cited by 141
Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in RatsHong C. Shen, Steven L. Colletti, James R. Tata et al.|Journal of Medicinal Chemistry|2009Cited by 80